HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Klaus Busam Selected Research

Complement System Proteins (Complement)

1/2016Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Klaus Busam Research Topics

Disease

30Neoplasms (Cancer)
10/2023 - 01/2002
30Melanoma (Melanoma, Malignant)
03/2023 - 12/2002
3Neoplasm Metastasis (Metastasis)
11/2012 - 10/2007
2Nevus (Nevi)
01/2022 - 07/2012
2Lymphatic Metastasis
01/2017 - 01/2004
1Insulinoma
10/2023
1Sinus Histiocytosis (Rosai-Dorfman Disease)
08/2019
1Vascular Malformations
01/2019
1Hemangioma (Angioma)
01/2019
1Lymphoma (Lymphomas)
07/2017
1Mycosis Fungoides
06/2016
1Bullous Pemphigoid (Pemphigoid)
01/2016
1Renal Cell Carcinoma (Grawitz Tumor)
01/2016
1Glioma (Gliomas)
01/2016
1Carcinogenesis
07/2012
1Infections
03/2012
1Hepatomegaly
12/2011
1Uveal melanoma
12/2011
1Sarcoma (Soft Tissue Sarcoma)
05/2008
1Neuroendocrine Carcinoma
02/2008
1Testicular Neoplasms (Testicular Cancer)
07/2007
1Cutaneous Malignant Melanoma
03/2007
1Skin Neoplasms (Skin Cancer)
09/2006
1Exanthema (Rash)
08/2006
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2006
1Vascular Skin Diseases
08/2006
1Porokeratosis (Palmoplantar Porokeratosis)
04/2006
1Carcinoma (Carcinomatosis)
10/2003

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
10/2023 - 12/2002
6DNA (Deoxyribonucleic Acid)IBA
09/2013 - 01/2002
4ParaffinIBA
01/2019 - 09/2013
4Formaldehyde (Formol)FDA Link
01/2019 - 09/2013
3Calcitriol Receptors (Calcitriol Receptor)IBA
01/2018 - 01/2012
3AntigensIBA
01/2017 - 07/2007
2relatlimabIBA
03/2023 - 11/2022
2NivolumabIBA
03/2023 - 11/2022
2Codon (Codons)IBA
01/2019 - 05/2012
2IpilimumabIBA
09/2013 - 08/2011
1Progesterone Receptors (Progesterone Receptor)IBA
10/2023
1Estrogen ReceptorsIBA
10/2023
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2023
1Messenger RNA (mRNA)IBA
12/2021
1Bexarotene (LGD1069)FDA Link
08/2019
1Vitamin DFDA LinkGeneric
01/2018
1Rituximab (Mabthera)FDA Link
07/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2016
1AutoantibodiesIBA
01/2016
1Monoclonal AntibodiesIBA
01/2016
1Complement System Proteins (Complement)IBA
01/2016
1Microphthalmia-Associated Transcription FactorIBA
05/2014
11-methyl-1-piperidinomethane sulfonateIBA
08/2013
1ChromatinIBA
02/2013
1CollagenIBA
02/2013
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
02/2013
1MicroRNAs (MicroRNA)IBA
11/2012
1Nucleic AcidsIBA
11/2012
1Apolipoproteins E (ApoE)IBA
11/2012
1Cyclin D1IBA
07/2012
1Alkaline PhosphataseIBA
12/2011
1Transaminases (Aminotransferases)IBA
12/2011
1Monophenol Monooxygenase (Tyrosinase)IBA
08/2011
1MART-1 AntigenIBA
08/2011
1AntibodiesIBA
08/2011
1Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA
12/2010
1Mitogen-Activated Protein KinasesIBA
12/2010
1Indicators and Reagents (Reagents)IBA
11/2010
1Cyclin-Dependent Kinase Inhibitor p16IBA
06/2008
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
06/2008
1MethyltransferasesIBA
05/2008
1Temozolomide (Temodar)FDA LinkGeneric
05/2008
1Angiogenesis InhibitorsIBA
05/2008
1ChromograninsIBA
02/2008
1SynaptophysinIBA
02/2008
1Matrix Metalloproteinases (MMPs)IBA
10/2007
1Peptides (Polypeptides)IBA
07/2007
1Cyclin-Dependent Kinases (cdk Proteins)IBA
05/2007
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2007
1Type 1 Melanocortin ReceptorIBA
09/2006
1Imatinib Mesylate (Gleevec)FDA Link
09/2006
1Phosphotransferases (Kinase)IBA
09/2006
1MitogensIBA
09/2006
1Biomarkers (Surrogate Marker)IBA
08/2006
1Bortezomib (Velcade)FDA Link
08/2006
1Proteasome InhibitorsIBA
08/2006
1lysyllysine (Lys-Lys)IBA
03/2006
1aspartyl-aspartic acid (Asp-Asp)IBA
03/2006
1ORALIT (ORS)IBA
03/2006
1ethyl 4(5)-imidazolecarboxylateIBA
03/2006
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2003
1Coloring Agents (Dyes)IBA
10/2003
1iso-sulfan blue (Lymphazurin)FDA LinkGeneric
10/2003
1RNA (Ribonucleic Acid)IBA
05/2003

Therapy/Procedure

6Therapeutics
09/2013 - 01/2002
3Lymph Node Excision (Lymph Node Dissection)
01/2009 - 01/2004
2Immunotherapy
09/2013 - 07/2007
2Radiotherapy
01/2004 - 10/2003
1Mohs Surgery (Mohs' Micrographic Surgery)
11/2019
1Ligation
06/2008
1Transplantation
04/2006
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2006